Process for the preparation of tryptase inhibitors

Details for Australian Patent Application No. 2005229319 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Sledeski, Adam W.; Tappertzhofen, Christoph; Graf, Claus-Dieter

Agent Watermark

Pub. Number AU-B-2005229319

PCT Pub. Number WO2005/095385

Priority 04004799.5 02.03.04 EP; 60/585,745 06.07.04 US

Filing date 18 February 2005

Wipo publication date 13 October 2005

Acceptance publication date 20 October 2011

International Classifications

C07D 211/02 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/26 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/53 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07F 7/10 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/095385 Priority application(s): WO2005/095385

20 October 2011 Application Accepted

  Published as AU-B-2005229319

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229320-Beta-aminoacid-derivatives as factor Xa inhibitors

2005229314-Frozen aerated product in a container and a method for manufacturing such